FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063156972> ?p ?o ?g. }

• W2063156972 endingPage "S650" @default.
• W2063156972 startingPage "S649" @default.
• W2063156972 abstract "Purpose/Objective(s)Our standard planning technique for locally advanced non-small cell lung cancer patients is a hybrid-IMRT (h-IMRT) technique with most of the dose delivered in an AP-PA direction, and 10-15% of the dose/fraction delivered with IMRT. Compared to 3-dimensional conformal radiation therapy, h-IMRT allows for improved planning target volume (PTV) coverage and better lung sparing. However, delivering 60-66 Gy to large PTVs can be challenging, and due to the relatively small IMRT contribution, h-IMRT offers limited possibilities for dose shaping and additional organ at risk (OAR) sparing. We therefore investigated the possible advantages of full volumetric modulated arc therapy (VMAT) planning.Materials/MethodsWe selected 14 patients with PTVs>750 cm3 (mean ± SD = 1096 ± 188 cm3) previously treated with concurrent chemoradiation therapy. H-IMRT plans delivering 33x2 Gy were compared with 2 coplanar VMAT approaches using either 2 or 4 arcs with avoidance sector to prevent beams entering through the contralateral lung. For treatment planning, a high priority was placed on sparing lung volume receiving ≥20 Gy (V20), V5 and contralateral lung V5 (CL-V5); spinal cord dose to be <50 Gy. In a sub-group of 4 patients further OAR sparing was evaluated with an additional 2 arcs plan that also aimed to reduce dose to skin, esophagus and heart.ResultsCompared to h-IMRT, VMAT significantly reduced V20 and mean lung dose (MLD), but significantly increased V5 and CL-V5. These improvements were at the expense of greater heterogeneity in PTV coverage (see Table). Use of 4 arcs only resulted in a higher PTV dose homogeneity compared to 2 arcs. Even without specific constraints, doses to skin and heart were lower in VMAT plans. In the sub-group of 4 patients planned with 2 arcs, further reductions in esophagus V60 (from 41 to 26%), mean esophagus dose (from 37 to 33 Gy) and skin V50 (from 23 to 14 cm3) were possible while maintaining heart and total lung doses. The trade-off was an increase in PTV heterogeneity (V95% from 95.6 to 94.2%).ConclusionsScientific Abstract 3114; Tableh-IMRTmean ± SD2 arcsmean ± SD4 arcsmean ± SDPTVV95% (%)97.8 ± 1.195.3 ± 1.495.7 ± 1.5V107% (cm3)23 ± 3797 ± 6550 ± 42Lungs-PTVV20 (%)28.9 ± 6.527.2 ± 6.227.1 ± 6.2V5 (%)51.0 ± 9.956.4 ± 11.155.8 ± 10.8Dmean (Gy)18.0 ± 3.616.1 ± 3.316.0 ± 3.3Contralateral lungV5 (%)31 ± 1340 ± 1340 ± 12HeartV60 (%)26 ± 2015 ± 1216 ± 12EsophagusDmean (Gy)36 ± 1035 ± 1035 ± 10SkinV50 (cm3)39 ± 2423 ± 1821 ± 18 Open table in a new tab Purpose/Objective(s)Our standard planning technique for locally advanced non-small cell lung cancer patients is a hybrid-IMRT (h-IMRT) technique with most of the dose delivered in an AP-PA direction, and 10-15% of the dose/fraction delivered with IMRT. Compared to 3-dimensional conformal radiation therapy, h-IMRT allows for improved planning target volume (PTV) coverage and better lung sparing. However, delivering 60-66 Gy to large PTVs can be challenging, and due to the relatively small IMRT contribution, h-IMRT offers limited possibilities for dose shaping and additional organ at risk (OAR) sparing. We therefore investigated the possible advantages of full volumetric modulated arc therapy (VMAT) planning. Our standard planning technique for locally advanced non-small cell lung cancer patients is a hybrid-IMRT (h-IMRT) technique with most of the dose delivered in an AP-PA direction, and 10-15% of the dose/fraction delivered with IMRT. Compared to 3-dimensional conformal radiation therapy, h-IMRT allows for improved planning target volume (PTV) coverage and better lung sparing. However, delivering 60-66 Gy to large PTVs can be challenging, and due to the relatively small IMRT contribution, h-IMRT offers limited possibilities for dose shaping and additional organ at risk (OAR) sparing. We therefore investigated the possible advantages of full volumetric modulated arc therapy (VMAT) planning. Materials/MethodsWe selected 14 patients with PTVs>750 cm3 (mean ± SD = 1096 ± 188 cm3) previously treated with concurrent chemoradiation therapy. H-IMRT plans delivering 33x2 Gy were compared with 2 coplanar VMAT approaches using either 2 or 4 arcs with avoidance sector to prevent beams entering through the contralateral lung. For treatment planning, a high priority was placed on sparing lung volume receiving ≥20 Gy (V20), V5 and contralateral lung V5 (CL-V5); spinal cord dose to be <50 Gy. In a sub-group of 4 patients further OAR sparing was evaluated with an additional 2 arcs plan that also aimed to reduce dose to skin, esophagus and heart. We selected 14 patients with PTVs>750 cm3 (mean ± SD = 1096 ± 188 cm3) previously treated with concurrent chemoradiation therapy. H-IMRT plans delivering 33x2 Gy were compared with 2 coplanar VMAT approaches using either 2 or 4 arcs with avoidance sector to prevent beams entering through the contralateral lung. For treatment planning, a high priority was placed on sparing lung volume receiving ≥20 Gy (V20), V5 and contralateral lung V5 (CL-V5); spinal cord dose to be <50 Gy. In a sub-group of 4 patients further OAR sparing was evaluated with an additional 2 arcs plan that also aimed to reduce dose to skin, esophagus and heart. ResultsCompared to h-IMRT, VMAT significantly reduced V20 and mean lung dose (MLD), but significantly increased V5 and CL-V5. These improvements were at the expense of greater heterogeneity in PTV coverage (see Table). Use of 4 arcs only resulted in a higher PTV dose homogeneity compared to 2 arcs. Even without specific constraints, doses to skin and heart were lower in VMAT plans. In the sub-group of 4 patients planned with 2 arcs, further reductions in esophagus V60 (from 41 to 26%), mean esophagus dose (from 37 to 33 Gy) and skin V50 (from 23 to 14 cm3) were possible while maintaining heart and total lung doses. The trade-off was an increase in PTV heterogeneity (V95% from 95.6 to 94.2%). Compared to h-IMRT, VMAT significantly reduced V20 and mean lung dose (MLD), but significantly increased V5 and CL-V5. These improvements were at the expense of greater heterogeneity in PTV coverage (see Table). Use of 4 arcs only resulted in a higher PTV dose homogeneity compared to 2 arcs. Even without specific constraints, doses to skin and heart were lower in VMAT plans. In the sub-group of 4 patients planned with 2 arcs, further reductions in esophagus V60 (from 41 to 26%), mean esophagus dose (from 37 to 33 Gy) and skin V50 (from 23 to 14 cm3) were possible while maintaining heart and total lung doses. The trade-off was an increase in PTV heterogeneity (V95% from 95.6 to 94.2%). ConclusionsScientific Abstract 3114; Tableh-IMRTmean ± SD2 arcsmean ± SD4 arcsmean ± SDPTVV95% (%)97.8 ± 1.195.3 ± 1.495.7 ± 1.5V107% (cm3)23 ± 3797 ± 6550 ± 42Lungs-PTVV20 (%)28.9 ± 6.527.2 ± 6.227.1 ± 6.2V5 (%)51.0 ± 9.956.4 ± 11.155.8 ± 10.8Dmean (Gy)18.0 ± 3.616.1 ± 3.316.0 ± 3.3Contralateral lungV5 (%)31 ± 1340 ± 1340 ± 12HeartV60 (%)26 ± 2015 ± 1216 ± 12EsophagusDmean (Gy)36 ± 1035 ± 1035 ± 10SkinV50 (cm3)39 ± 2423 ± 1821 ± 18 Open table in a new tab" @default.
• W2063156972 created "2016-06-24" @default.
• W2063156972 creator A5027536867 @default.
• W2063156972 creator A5028297878 @default.
• W2063156972 creator A5068938553 @default.
• W2063156972 creator A5077453712 @default.
• W2063156972 creator A5083123058 @default.
• W2063156972 date "2014-09-01" @default.
• W2063156972 modified "2023-09-26" @default.
• W2063156972 title "VMAT Planning for Large Volume Stage III Lung Cancer" @default.
• W2063156972 doi "https://doi.org/10.1016/j.ijrobp.2014.05.1922" @default.
• W2063156972 hasPublicationYear "2014" @default.
• W2063156972 type Work @default.
• W2063156972 sameAs 2063156972 @default.
• W2063156972 citedByCount "0" @default.
• W2063156972 crossrefType "journal-article" @default.
• W2063156972 hasAuthorship W2063156972A5027536867 @default.
• W2063156972 hasAuthorship W2063156972A5028297878 @default.
• W2063156972 hasAuthorship W2063156972A5068938553 @default.
• W2063156972 hasAuthorship W2063156972A5077453712 @default.
• W2063156972 hasAuthorship W2063156972A5083123058 @default.
• W2063156972 hasBestOaLocation W20631569721 @default.
• W2063156972 hasConcept C121332964 @default.
• W2063156972 hasConcept C143998085 @default.
• W2063156972 hasConcept C146357865 @default.
• W2063156972 hasConcept C151730666 @default.
• W2063156972 hasConcept C20556612 @default.
• W2063156972 hasConcept C2776256026 @default.
• W2063156972 hasConcept C2989005 @default.
• W2063156972 hasConcept C62520636 @default.
• W2063156972 hasConcept C71924100 @default.
• W2063156972 hasConcept C86803240 @default.
• W2063156972 hasConceptScore W2063156972C121332964 @default.
• W2063156972 hasConceptScore W2063156972C143998085 @default.
• W2063156972 hasConceptScore W2063156972C146357865 @default.
• W2063156972 hasConceptScore W2063156972C151730666 @default.
• W2063156972 hasConceptScore W2063156972C20556612 @default.
• W2063156972 hasConceptScore W2063156972C2776256026 @default.
• W2063156972 hasConceptScore W2063156972C2989005 @default.
• W2063156972 hasConceptScore W2063156972C62520636 @default.
• W2063156972 hasConceptScore W2063156972C71924100 @default.
• W2063156972 hasConceptScore W2063156972C86803240 @default.
• W2063156972 hasIssue "1" @default.
• W2063156972 hasLocation W20631569721 @default.
• W2063156972 hasOpenAccess W2063156972 @default.
• W2063156972 hasPrimaryLocation W20631569721 @default.
• W2063156972 hasRelatedWork W1967103478 @default.
• W2063156972 hasRelatedWork W2032912323 @default.
• W2063156972 hasRelatedWork W2148097028 @default.
• W2063156972 hasRelatedWork W2356105190 @default.
• W2063156972 hasRelatedWork W2365632055 @default.
• W2063156972 hasRelatedWork W2372561159 @default.
• W2063156972 hasRelatedWork W2375344515 @default.
• W2063156972 hasRelatedWork W2380382254 @default.
• W2063156972 hasRelatedWork W2390152934 @default.
• W2063156972 hasRelatedWork W2412727163 @default.
• W2063156972 hasVolume "90" @default.
• W2063156972 isParatext "false" @default.
• W2063156972 isRetracted "false" @default.
• W2063156972 magId "2063156972" @default.
• W2063156972 workType "article" @default.